Mesoblast, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersNew York, NY
US patents30
SAM.gov UEINNVGHSW7VLM7
CAGE code4QWB3
Incorporated inDE
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
30 US patents granted 2013–2025, 4 of them in the five years to SEP 2025.
Pharmaceuticals 27Measurement 3
- Isolation of adult multipotential cells by tissue non-specific alkaline phosphataseUS 12,275,801 · granted APR 15, 2025
- Methods of generating, repairing and/or maintaining connective tissue in vivoUS 12,220,433 · granted FEB 11, 2025
- Methods for increasing osteoblastic functionUS 11,135,249 · granted OCT 5, 2021
- Method of treating graft versus host diseaseUS 10,849,932 · granted DEC 1, 2020
- Methods of treating or preventing respiratory conditionsUS 10,688,134 · granted JUN 23, 2020
Newest 5 shown · Granted to Mesoblast, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Mesoblast, INC. | New York | NY | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.